受强制性开放获取政策约束的文章 - Anupma Nayak了解详情
可在其他位置公开访问的文章：22 篇
ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer
S Kumar, DW Wilkes, N Samuel, MA Blanco, A Nayak, K Alicea-Torres, ...
The Journal of Clinical Investigation 128 (11), 5095-5109, 2018
强制性开放获取政策： US National Institutes of Health
Polyunsaturated fatty acids from astrocytes activate PPARγ signaling in cancer cells to promote brain metastasis
Y Zou, A Watters, N Cheng, CE Perry, K Xu, GM Alicea, JLD Parris, ...
Cancer Discovery 9 (12), 1720-1735, 2019
强制性开放获取政策： US National Institutes of Health, V Foundation, USA, Susan G. Komen
Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer
S Kumar, RK Srivastav, DW Wilkes, T Ross, S Kim, J Kowalski, S Chatla, ...
Oncogene 38 (12), 2092-2107, 2019
强制性开放获取政策： US National Institutes of Health
Genomic signatures predict the immunogenicity of BRCA-deficient breast cancer
AA Kraya, KN Maxwell, B Wubbenhorst, BM Wenz, J Pluta, AJ Rech, ...
Clinical Cancer Research 25 (14), 4363-4374, 2019
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
PTK6 inhibition suppresses metastases of triple-negative breast cancer via SNAIL-dependent E-cadherin regulation
K Ito, SH Park, A Nayak, JH Byerly, HY Irie
Cancer research 76 (15), 4406-4417, 2016
强制性开放获取政策： Susan G. Komen
Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision
A Nayak, S Carkaci, MZ Gilcrease, P Liu, LP Middleton, RL Bassett Jr, ...
Clinical breast cancer 13 (6), 439-449, 2013
强制性开放获取政策： US National Institutes of Health
Immature natural killer cells promote progression of triple-negative breast cancer
G Thacker, S Henry, A Nandi, R Debnath, S Singh, A Nayak, B Susnik, ...
Science translational medicine 15 (686), eabl4414, 2023
强制性开放获取政策： US National Institutes of Health
Insulin resistance contributes to racial disparities in breast cancer prognosis in US women
EJ Gallagher, K Fei, SM Feldman, E Port, NB Friedman, SK Boolbol, ...
Breast Cancer Research 22, 1-10, 2020
强制性开放获取政策： US National Institutes of Health
Breast cancer 18F-ISO-1 uptake as a marker of proliferation status
ES McDonald, RK Doot, AJ Young, EK Schubert, J Tchou, DA Pryma, ...
Journal of Nuclear Medicine 61 (5), 665-670, 2020
强制性开放获取政策： US Department of Energy, US National Institutes of Health, Susan G. Komen
EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice
Z Zelenko, EJ Gallagher, IM Antoniou, D Sachdev, A Nayak, D Yee, ...
Endocrine-related cancer 23 (9), 747-758, 2016
强制性开放获取政策： US National Institutes of Health
Dll1-mediated notch signaling drives tumor cell cross-talk with cancer-associated fibroblasts to promote radioresistance in breast cancer
A Nandi, R Debnath, A Nayak, TKJ To, G Thacker, M Reilly, S Gumber, ...
Cancer research 82 (20), 3718-3733, 2022
强制性开放获取政策： US Department of Defense, US National Institutes of Health
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers
JB Shah, D Pueschl, B Wubbenhorst, M Fan, J Pluta, K D’Andrea, ...
Nature communications 13 (1), 6728, 2022
强制性开放获取政策： US National Institutes of Health, Government of Spain, V Foundation, USA
A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for …
S Hamalian, R Güth, F Runa, F Sanchez, E Vickers, M Agajanian, ...
Oncogene 40 (33), 5224-5235, 2021
强制性开放获取政策： US National Science Foundation, US Department of Defense, US National …
Metabolic syndrome and pre‐diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways
EJ Gallagher, D LeRoith, R Franco, IM Antoniou, A Nayak, ...
Diabetes/metabolism research and reviews 32 (7), 745-753, 2016
强制性开放获取政策： US National Institutes of Health
PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer
AA Kraya, KN Maxwell, MA Eiva, B Wubbenhorst, J Pluta, M Feldman, ...
JCO Precision Oncology 6, e2100159, 2022
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Analysis of ALK gene in 133 patients with breast cancer revealed polysomy of chromosome 2 and no ALK amplification
MG Hanna, V Najfeld, HY Irie, J Tripodi, A Nayak
Springerplus 4, 1-6, 2015
强制性开放获取政策： UK Medical Research Council
Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers
D Wineland, AN Le, R Hausler, G Kelly, E Barrett, H Desai, ...
JCO Precision Oncology 7, e2300036, 2023
强制性开放获取政策： US National Institutes of Health, V Foundation, USA
Statin use and breast cancer prognosis in black and white women
A Leiter, NA Bickell, D LeRoith, A Nayak, SM Feldman, NB Friedman, ...
Hormones and Cancer 9, 55-61, 2018
强制性开放获取政策： US National Institutes of Health
244MO A phase II trial targeting disseminated dormant tumor cells with hydroxychloroquine, everolimus or the combination to prevent recurrent breast cancer (“CLEVER”)
A DeMichele, AS Clark, L Bayne, K Rohn, I Nivar, P Wileyto, L Berry, ...
Annals of Oncology 34, S281, 2023
强制性开放获取政策： US National Institutes of Health
Clinicopathologic predictors of clinical outcomes in mammary adenoid cystic carcinoma: a multi-institutional study
T Khoury, M Rosa, A Nayak, R Karabakhtsian, O Fadare, Z Li, B Turner, ...
Modern Pathology 36 (2), 100006, 2023
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定